Your browser doesn't support javascript.
loading
Development of TP53 mutations over the course of therapy for acute myeloid leukemia.
Alwash, Yasmin; Khoury, Joseph D; Tashakori, Mehrnoosh; Kanagal-Shamanna, Rashmi; Daver, Naval; Ravandi, Farhad; Kadia, Tapan M; Konopleva, Marina; Dinardo, Courtney D; Issa, Ghayas C; Loghavi, Sanam; Takahashi, Koichi; Jabbour, Elias; Guerra, Veronica; Kornblau, Steven; Kantarjian, Hagop; Short, Nicholas J.
Afiliación
  • Alwash Y; The Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Khoury JD; The Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Tashakori M; The Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kanagal-Shamanna R; The Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Daver N; The Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Ravandi F; The Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kadia TM; The Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Konopleva M; The Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Dinardo CD; The Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Issa GC; The Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Loghavi S; The Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Takahashi K; The Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Jabbour E; The Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Guerra V; The Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kornblau S; The Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Kantarjian H; The Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Short NJ; The Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Am J Hematol ; 96(11): 1420-1428, 2021 11 01.
Article en En | MEDLINE | ID: mdl-34351647
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Proteína p53 Supresora de Tumor Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Am J Hematol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Proteína p53 Supresora de Tumor Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Am J Hematol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos